Physician

Edmond Ghahramani, M.D.

According to 2025 Medicare claims, Edmond Ghahramani, M.D. (NPI: 1982800199) practices family practice in the Modesto, CA market, with the plurality of this provider's patient population coming from Stanislaus, CA. This provider's primary affiliated billing organization is SUTTER VALLEY MEDICAL FOUNDATION (NPI: 1669846986; TIN: 680273974) and primary practice location at 95382-8000. Ghahramani is affiliated with the Sutter Medicare Direct (ACO ID: A5279), participating under the MSSP model.

Ghahramani's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 721 traditional Medicare patients, billed 6,573 HCPCS/CPT codes, and received $305,298 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 19,775 prescription claims across 1,023 beneficiaries totaling $1,659,288 in drug costs, led by Januvia (Sitagliptin Phosphate). DME data shows 827 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. For DME billing, reported payments rose steadily, from $32,875 to $77,453.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	684	6,763	$275,043
2016	668	6,498	$315,753
2017	645	4,594	$250,865
2018	629	4,870	$246,685
2019	639	4,742	$258,824
2020	602	3,806	$213,209
2021	625	4,019	$276,717
2022	606	4,040	$294,006
2023	683	4,146	$283,699
2024	721	6,573	$305,298

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	852	16,012	$1,398,201
2016	852	19,852	$1,908,085
2017	977	20,566	$1,917,933
2018	966	21,596	$2,123,105
2019	994	20,514	$2,183,462
2020	1,000	20,746	$2,215,362
2021	1,009	19,872	$2,219,110
2022	960	19,448	$2,240,297
2023	967	18,376	$2,218,129
2024	1,023	19,775	$1,659,288

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	188	554	$18,324
2016	295	792	$20,645
2017	170	611	$9,619
2018	258	831	$22,054
2019	236	789	$17,007
2020	263	921	$25,303
2021	247	936	$32,663
2022	297	1,100	$26,442
2023	250	1,023	$32,071
2024	161	827	$19,217

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	222	222	$132
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	684	2,143	$88
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	502	826	$13
96372	Injection of drug or substance under skin or into muscle	153	440	$10
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	153	455	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Januvia	Sitagliptin Phosphate	167	11,700	$190,984
Linzess	Linaclotide	119	8,880	$160,445
Jardiance	Empagliflozin	89	6,810	$122,712
Ozempic	Semaglutide	81	3,360	$105,457
Eliquis	Apixaban	117	5,120	$95,668

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	13	104	$6,815
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	89	275	$3,000
E0260	Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress	Y	N/R	43	$1,865
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	76	$1,151
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	15	47	$1,087

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Edmond Ghahramani, M.D.?

Tedicare shows public-source Medicare data for Edmond Ghahramani, M.D. (NPI 1982800199), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Edmond Ghahramani, M.D. have ACO affiliation data?

Edmond Ghahramani, M.D. is shown with ACO affiliation data for Sutter Medicare Direct (MSSP, ACO ID A5279).

What billing organization is linked to Edmond Ghahramani, M.D.?

Edmond Ghahramani, M.D. is linked to SUTTER VALLEY MEDICAL FOUNDATION (billing NPI 1669846986) in the available physician profile data.

Does Edmond Ghahramani, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.